<i>Pseudomonas aeruginosa</i> infection is linked to increases in cardiovascular events post exacerbation in bronchiectasis
PsA infection in patients with BE is associated with an increased risk of CV events following a baseline exacerbation. These data highlight the multisystemic nature of BE and the need to raise awareness of the potential increased risk of CV events in patients with BE experiencing exacerbations.
Authors
- Engin Baturcam (ORCID: https://orcid.org/0000-0001-5879-6329)
- Claudia Cabrera (ORCID: https://orcid.org/0000-0003-2778-1604)
- Caroline Ann Owen (ORCID: https://orcid.org/0000-0003-4377-3591)
- Fred Reid
- Charles Haworth (ORCID: https://orcid.org/0000-0001-7126-2874)
- Rod Hughes (ORCID: https://orcid.org/0009-0006-1200-5580)
Institutions
- University of Ulster (GB)
- University of Cambridge (GB)
- Royal Papworth Hospital (GB)
- AstraZeneca (Netherlands) (NL)
- AstraZeneca (Singapore) (SG)
- Royal Victoria Hospital (GB)
- AstraZeneca (Poland) (PL)
- AstraZeneca (Finland) (FI)
- AstraZeneca (Italy) (IT)
- AstraZeneca (Spain) (ES)
Publication Details
- Journal
- ERJ Open Research
- Published
- 2025-02-06
- DOI
- https://doi.org/10.1183/23120541.01126-2024
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00